Refractory Systemic Lupus Erythematosus Sle clinical trials

Explore recruiting refractory systemic lupus erythematosus sle clinical trials.

Recruiting refractory systemic lupus erythematosus sle studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Refractory Systemic Lupus Erythematosus Sle trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

MB-CART19.1 in refractory SLE

Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 2, open-label study to evaluate the efficacy and safety of rapcabtagene autoleucel in patients with active, refractory systemic lupus erythematosus (SLE), or active, refractory lupus nephritis (LN).

France, Spain, Italy, Netherlands, Germany, Czechia +7 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Refractory Systemic Lupus Erythematosus Sle trials by city

Refractory Systemic Lupus Erythematosus Sle in Toronto Refractory Systemic Lupus Erythematosus Sle in Vancouver Refractory Systemic Lupus Erythematosus Sle in Montreal Refractory Systemic Lupus Erythematosus Sle in Calgary Refractory Systemic Lupus Erythematosus Sle in Edmonton Refractory Systemic Lupus Erythematosus Sle in Ottawa Refractory Systemic Lupus Erythematosus Sle in Winnipeg Refractory Systemic Lupus Erythematosus Sle in Quebec City Refractory Systemic Lupus Erythematosus Sle in Hamilton Refractory Systemic Lupus Erythematosus Sle in Kitchener Refractory Systemic Lupus Erythematosus Sle in London Refractory Systemic Lupus Erythematosus Sle in Halifax Refractory Systemic Lupus Erythematosus Sle in New York Refractory Systemic Lupus Erythematosus Sle in Los Angeles Refractory Systemic Lupus Erythematosus Sle in Chicago Refractory Systemic Lupus Erythematosus Sle in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease